SUN PHARMACEUTICAL INDUSTRIES
Back to Income Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹47.84 | ₹45.55 | ₹39.91 | ₹35.32 | ₹13.64 |
What is the latest Earnings Per Share (EPS) of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹47.84 |
| Mar2025 | ₹45.55 |
| Mar2024 | ₹39.91 |
| Mar2023 | ₹35.32 |
| Mar2022 | ₹13.64 |
How is Earnings Per Share (EPS) of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹47.84 | 5.03 | |
| Mar2025 | ₹45.55 | 14.13 | |
| Mar2024 | ₹39.91 | 13.00 | |
| Mar2023 | ₹35.32 | 158.94 | |
| Mar2022 | ₹13.64 | - | |
Compare Earnings Per Share (EPS) of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,778.6 Cr | 0.5% | 6.8% | 16.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,590.0 Cr | 0.6% | 8.7% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,658.0 Cr | 0.4% | 13.8% | 46.9% | Stock Analytics | |
| CIPLA | ₹115,728.0 Cr | -0.4% | 5.8% | -2.9% | Stock Analytics | |
| MANKIND PHARMA | ₹106,460.0 Cr | 1.2% | 6.6% | -5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,708.0 Cr | -1.9% | -5.1% | -2.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 0.5% |
6.8% |
16.3% |
| SENSEX | 0.5% |
0.1% |
-6.1% |
You may also like the below Video Courses